Latest News
MapLight Therapeutics, Inc.
- MapLight Therapeutics CMO Erin Foff sells $124,068 in stock
- MapLight Therapeutics chief scientific officer sells $93,025 in shares
- MapLight Therapeutics CAO sells $82,149 in shares
- MapLight Therapeutics general counsel reports $72,881 stock sale
- MapLight Therapeutics’ Kreitzer sells $96,024 in common stock
- Form 4 MapLight Therapeutics Inc: Jonathan Gillis (CAO and Interim CFO) For: 15 October
- Form 4 MapLight Therapeutics Inc: Anatol Kreitzer (Chief Discovery Officer) For: 15 October
- Form 144 MapLight Therapeutics For: 16 October By Investing.com
- MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
- MapLight co-founder is joint winner of 2026 Nobel Prize in Medicine
- MapLight Therapeutics (MPLT) Slides 5.50% as Shares Test Support Near $9.15 - Ratio Spread Trade
- Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →